Viewpoint

Some see the financial catastrophe as a way to kick start a new cycle. But conditions may not be right for an innovation-led boom, says Sami Mahroum.

Political leaders love innovation and want more of it, but they need to have the right policies, says innovation guide Joachim von Heimburg.

Innovation through R&D, not tax-payer funded scrappage subsidies, is the only way for the car industry to rescue itself, writes Nuala Moran.

Basic and applied research are not either/ors. Both should be funded to beat the slump, says Nuala Moran.

Money is not the lure for expats moving back to Asia. This calls for a rethink of how to retain talent in Europe and North America, says Nuala Moran.

Prickly issues like IP and publication rights should no longer be allowed to dilute academic-industrial partnerships, writes Nuala Moran.

It’s no great revelation that the biotech funding model is broken, yet the market for the industry’s drugs has never been greater. So where is the fix, asks Nuala Moran.

The EU doesn’t do fundamental research, which is why it has taken 20 years for researchers involved in high risk research to get together, but it can’t get by without it.

As life sciences investors shy away from drug development and opt for lower-risk devices and diagnostics, what can Europe learn from Israel’s experience?

As governments direct stimulus packages towards science and research, don’t forget the current crop of spin-outs who face extinction in a frozen capital market, writes Nuala Moran.